SUBSEQUENT EVENTS	6 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 23 – SUBSEQUENT EVENTS The Company has evaluated subsequent events from the balance sheet date through the date on which these unaudited condensed consolidated financial statements were issued. Other than as described in the notes below, the Company did not have any material subsequent events that impacted its unaudited condensed consolidated financial statements or disclosures. Change in Independent Registered Public Accounting Firm Effective July 8, 2026, the Audit Committee of the Board of Directors approved the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm, succeeding CBIZ CPAs P.C. The change was reported under Item 4.01 of a Current Report on Form 8-K and is also described in Part II, Item 5 of this Quarterly Report on Form 10-Q. The change had no effect on the Company’s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2026. Stock Repurchase Program On July 1, 2026, the Board of Directors authorized a stock repurchase program permitting the repurchase of up to 10,000,000 shares of the Company’s common stock at a purchase price not exceeding $2.00 per share. No shares had been repurchased under the authorization as of the filing date of this Quarterly Report on Form 10-Q. The Company’s liquidity assessment and going concern evaluation as of June 30, 2026 do not assume repurchases under the authorization. GLDY Liquidity Loan Agreement On July 1, 2026, the Company disbursed 1,069 GLDY tokens and $5,000 of USDC to an independent proprietary trading firm under an interest-free loan agreement entered into on May 14, 2026 to support secondary-market liquidity for GLDY. Either party may terminate the agreement at any time on 30 days’ prior written notice, or immediately upon an event of default, and the loaned assets are then returnable within two business days. Equity Transactions Between July 1, 2026 and August 14, 2026, an aggregate of 645,578 Exchangeable Shares were converted into the same number of shares of the Company’s common stock by holders of Exchangeable Shares. Between July 1, 2026 and August 14, 2026, the Company issued 3,197,044 shares of common stock upon the vesting and settlement of restricted stock units and restricted stock awards, of which 453,125 shares were issued to related parties, consisting of certain executive officers and directors of the Company. On July 1, 2026, the Company entered into amendments to previously granted restricted stock unit award agreements with the Company’s Chief Executive Officer, President, Chief Investment Officer and Chief Financial Officer, each of whom other than the Chief Financial Officer also serves as a member of the Board of Directors. The amendments modified the next quarterly vesting date of the unvested portions of those awards from July 2026 to August 1, 2026. The amendments did not change the number of units awarded, the settlement terms, or the overall vesting term of any award, and units that had vested prior to the effective date of the amendments were unaffected. The modifications did not result in incremental compensation cost. On July 1, 2026 and July 6, 2026, the Company granted restricted stock unit awards for an aggregate of 115,000 shares of common stock to two employees under the Company’s 2023 Equity Incentive Plan. The awards vest in equal quarterly installments over four years from the respective dates of grant, subject to continued service. No shares were issued in respect of these awards during the period from July 1, 2026 through August 14, 2026.

SUBSEQUENT EVENTS

6 Months Ended

Jun. 30, 2026

NOTE 23 – SUBSEQUENT EVENTS

The Company has evaluated subsequent events from the balance sheet date through the date on which these unaudited condensed consolidated financial statements were issued. Other than as described in the notes below, the Company did not have any material subsequent events that impacted its unaudited condensed consolidated financial statements or disclosures.

Change in Independent Registered Public Accounting Firm

Effective July 8, 2026, the Audit Committee of the Board of Directors approved the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm, succeeding CBIZ CPAs P.C. The change was reported under Item 4.01 of a Current Report on Form 8-K and is also described in Part II, Item 5 of this Quarterly Report on Form 10-Q. The change had no effect on the Company’s unaudited condensed consolidated financial statements as of and for the three and six months ended June 30, 2026.

Stock Repurchase Program

On July 1, 2026, the Board of Directors authorized a stock repurchase program permitting the repurchase of up to 10,000,000 shares of the Company’s common stock at a purchase price not exceeding $2.00 per share. No shares had been repurchased under the authorization as of the filing date of this Quarterly Report on Form 10-Q. The Company’s liquidity assessment and going concern evaluation as of June 30, 2026 do not assume repurchases under the authorization.

GLDY Liquidity Loan Agreement

On July 1, 2026, the Company disbursed 1,069 GLDY tokens and $5,000 of USDC to an independent proprietary trading firm under an interest-free loan agreement entered into on May 14, 2026 to support secondary-market liquidity for GLDY. Either party may terminate the agreement at any time on 30 days’ prior written notice, or immediately upon an event of default, and the loaned assets are then returnable within two business days.

Equity Transactions

Between July 1, 2026 and August 14, 2026, an aggregate of 645,578 Exchangeable Shares were converted into the same number of shares of the Company’s common stock by holders of Exchangeable Shares.

Between July 1, 2026 and August 14, 2026, the Company issued 3,197,044 shares of common stock upon the vesting and settlement of restricted stock units and restricted stock awards, of which 453,125 shares were issued to related parties, consisting of certain executive officers and directors of the Company.

On July 1, 2026, the Company entered into amendments to previously granted restricted stock unit award agreements with the Company’s Chief Executive Officer, President, Chief Investment Officer and Chief Financial Officer, each of whom other than the Chief Financial Officer also serves as a member of the Board of Directors. The amendments modified the next quarterly vesting date of the unvested portions of those awards from July 2026 to August 1, 2026. The amendments did not change the number of units awarded, the settlement terms, or the overall vesting term of any award, and units that had vested prior to the effective date of the amendments were unaffected. The modifications did not result in incremental compensation cost.

On July 1, 2026 and July 6, 2026, the Company granted restricted stock unit awards for an aggregate of 115,000 shares of common stock to two employees under the Company’s 2023 Equity Incentive Plan. The awards vest in equal quarterly installments over four years from the respective dates of grant, subject to continued service. No shares were issued in respect of these awards during the period from July 1, 2026 through August 14, 2026.